Stox
20
Zota Health Care LImited
NSE: ZOTA · Unclassified
₹1,231.10+1.01%06 Nov 2026
Check figures: unusual quarterly results in JUN '26 (₹-43.56 cr vs a typical ₹3.08 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.
Ask the data
Instant answers about Zota Health Care LImited — computed from its filings, no language modelMarket cap₹4,264 cr
Current price₹1,231.10
High / Low₹1,687 / ₹1,028
P/E—
P/B6.82
Book value₹180.6
ROE-18.0%
ROCE-15.2%
Debt / equity0.05
Dividend yield0.07%
EPS (TTM)₹-32.57
Face value₹10
Price & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | 95.1 | 106.8 | 131.2 | 140.0 | 180.5 | 293.0 | 538.7 |
| EBITDA | 4.5 | 0.6 | 14.8 | 7.3 | 7.5 | -5.7 | 18.5 |
| Operating margin | 4.8% | 0.6% | 11.3% | 5.2% | 4.2% | -2.0% | 3.4% |
| Interest | 0.1 | 0.1 | 0.3 | 2.6 | 4.8 | 10.8 | 17.4 |
| Depreciation | 2.1 | 3.2 | 3.7 | 12.0 | 20.1 | 43.2 | 82.5 |
| Profit before tax | 3.9 | -0.4 | 12.4 | -4.7 | -16.2 | -57.6 | -79.8 |
| Tax | 1.1 | -0.2 | 3.5 | 1.1 | -1.8 | -0.9 | -5.8 |
| Net profit | 2.7 | -0.2 | 8.9 | -5.8 | -14.3 | -56.4 | -73.9 |
| EPS ₹ | 1.12 | -0.09 | 3.58 | -2.29 | -5.59 | -20.68 | -22.46 |
| Operating cash flow | — | — | 13.3 | -2.0 | -6.0 | -50.0 | -84.4 |
| Capex | — | — | 3.2 | 12.5 | 0.0 | 0.0 | 0.0 |
| Dividend paid | — | — | 2.5 | 3.8 | 2.6 | 2.7 | 3.1 |
| Total assets | — | — | — | 158.1 | 228.3 | 439.1 | 1,131.0 |
| Equity | — | — | — | 80.4 | 90.0 | 223.7 | 693.5 |
Quarterly performance
last 28 quarters · ₹ crore| SEP '19 | DEC '19 | MAR '20 | JUN '20 | SEP '20 | DEC '20 | MAR '21 | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.3 | 25.1 | 23.1 | 17.6 | 28.2 | 30.5 | 30.6 | 33.4 | 35.4 | 31.0 | 31.3 | 29.2 | 39.0 | 36.9 | 38.6 | 45.3 | 46.9 | 49.6 | 56.3 | 67.3 | 72.1 | 97.3 | 103.6 | 128.9 | 142.9 | 163.2 | 173.6 | 199.3 |
| Operating profit | 1.4 | 0.7 | 1.5 | 1.1 | 0.8 | -1.2 | -0.2 | 4.9 | 4.9 | 5.0 | 0.1 | 1.4 | 4.8 | 1.0 | 1.3 | 4.4 | 3.3 | -1.5 | -1.3 | -0.9 | -6.1 | 2.5 | 4.0 | 6.3 | -0.4 | 8.7 | -11.6 | 3.1 |
| Operating margin | 5.6% | 2.9% | 6.5% | 6.6% | 3.0% | -3.9% | -0.6% | 14.6% | 13.7% | 16.1% | 0.2% | 4.9% | 12.4% | 2.8% | 3.3% | 9.8% | 7.1% | -3.0% | -2.2% | -1.3% | -8.4% | 2.5% | 3.8% | 4.9% | -0.3% | 5.3% | -6.7% | 1.5% |
| Other income | 0.4 | 0.3 | 0.5 | 0.2 | 0.2 | 0.6 | 0.2 | 0.3 | 0.2 | 0.3 | 0.8 | 0.5 | 0.8 | 0.0 | 0.1 | 0.4 | 0.1 | 0.5 | 0.0 | 0.5 | 0.5 | 1.0 | 0.9 | 1.6 | 1.7 | 3.2 | 2.0 | 4.9 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.4 | 0.7 | 0.8 | 0.8 | 1.1 | 1.1 | 1.7 | 2.9 | 2.9 | 1.6 | 3.5 | 3.2 | 3.8 | 5.0 | 5.3 | 6.3 | 6.4 |
| Depreciation | 0.3 | 0.5 | 1.0 | 0.7 | 0.8 | 0.8 | 0.9 | 0.6 | 0.7 | 0.8 | 1.6 | 1.9 | 2.9 | 3.9 | 3.4 | 4.8 | 5.1 | 6.8 | 8.0 | 9.5 | 11.3 | 14.3 | 14.7 | 18.5 | 22.3 | 27.0 | 27.8 | 28.7 |
| Profit before tax | 1.5 | 0.5 | 1.0 | 0.6 | 1.3 | -1.4 | -0.9 | 4.6 | 4.3 | 4.5 | -1.0 | -0.4 | 2.1 | -3.1 | -2.8 | -1.1 | -2.7 | -9.5 | -12.2 | -12.7 | -18.5 | -14.3 | -13.1 | -14.4 | -25.9 | -26.4 | -43.6 | -27.1 |
| Tax | 0.4 | 0.2 | 0.3 | 0.1 | 0.3 | -0.4 | -0.1 | 1.2 | 1.1 | 1.2 | 0.0 | 0.4 | 1.2 | -0.5 | 0.0 | 0.5 | 0.2 | -2.6 | 0.6 | -0.5 | 0.5 | -1.4 | 0.7 | 1.8 | 3.7 | -12.0 | 0.3 | -1.1 |
| Net profit | 1.1 | 0.4 | 0.7 | 0.5 | 1.0 | -1.0 | -0.7 | 3.4 | 3.2 | 3.3 | -1.0 | -0.8 | 0.9 | -2.6 | -2.8 | -1.6 | -2.9 | -6.9 | -12.7 | -12.1 | -18.7 | -12.9 | -14.3 | -15.9 | -29.5 | -14.2 | -43.6 | -25.6 |
| EPS ₹ | 0.44 | 0.15 | 0.29 | 0.21 | 0.41 | -0.41 | -0.30 | 1.37 | 1.30 | 1.33 | -0.40 | -0.33 | 0.36 | -1.05 | -1.13 | -0.64 | -1.14 | -2.68 | -4.80 | -4.57 | -6.80 | -4.57 | -4.92 | -5.26 | -9.44 | -4.13 | -12.58 | -7.39 |
| Revenue YoY | — | — | — | — | 11.4% | 21.6% | 32.5% | 90.5% | 25.6% | 1.8% | 2.5% | -12.7% | 10.1% | 17.6% | 32.4% | 16.2% | — | 34.7% | 45.7% | 48.6% | 53.7% | 96.0% | 84.0% | 91.7% | 98.2% | 67.8% | 67.6% | 54.6% |
| Profit YoY | — | — | — | — | -6.4% | -365.8% | -202.8% | 560.8% | 214.7% | — | — | -124.3% | -71.7% | — | — | -281.3% | — | — | — | — | — | — | — | — | — | — | — | — |
Returns & margins
trailing-twelve-month, per quarter| JUN '20 | SEP '20 | DEC '20 | MAR '21 | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | 2.8% | -9.9% | -15.9% | -26.9% | -21.8% | -31.7% | -25.2% | -25.9% | -19.6% | -23.0% | -10.7% | -14.9% | -18.0% |
| ROCE | — | — | — | — | — | — | — | — | — | 7.7% | -5.7% | -10.9% | -17.8% | -17.7% | -27.2% | -20.4% | -20.7% | -14.9% | -16.2% | -8.6% | -12.5% | -15.2% |
| Net margin | 3.0% | 2.8% | 1.2% | -0.2% | 2.2% | 3.7% | 7.0% | 6.8% | 3.7% | 1.9% | -6.0% | -8.0% | -12.2% | -15.8% | -20.6% | -19.2% | -17.0% | -15.4% | -15.4% | -13.7% | -17.0% | -16.6% |
| EBITDA margin | 5.3% | 4.5% | 2.3% | 0.6% | 3.6% | 6.4% | 11.2% | 11.3% | 8.9% | 8.7% | 6.0% | 4.2% | 2.5% | -0.1% | -3.9% | -2.0% | -0.1% | 1.7% | 2.6% | 3.4% | 0.5% | -0.0% |
| Debt / equity | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.16 | 0.16 | 0.01 | 0.01 | 0.03 | 0.03 | 0.02 | 0.02 | 0.04 | 0.04 | 0.05 |
| Interest coverage | 62.00 | 59.50 | 22.71 | -2.60 | 36.60 | 66.90 | 158.12 | 41.13 | 12.03 | 4.99 | -1.48 | -2.37 | -2.72 | -3.33 | -4.87 | -4.35 | -4.27 | -3.98 | -3.37 | -3.60 | -4.39 | -4.35 |
| Asset turnover | — | — | — | — | — | — | — | — | — | 0.83 | 0.91 | 0.79 | 0.87 | 0.70 | 0.77 | 0.67 | 0.77 | 0.66 | 0.78 | 0.48 | 0.54 | 0.62 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '22 | MAR '23 | SEP '23 | MAR '24 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Share capital | 25.2 | 25.2 | 25.9 | 25.9 | 27.4 | 28.6 | 30.6 | 34.6 | 34.6 |
| Other equity / reserves | 60.9 | 55.2 | 76.2 | 64.1 | 131.6 | 195.1 | 285.1 | 658.9 | 591.0 |
| Total equity | 86.0 | 80.4 | 102.1 | 90.0 | 159.0 | 223.7 | 315.7 | 693.5 | 625.6 |
| Borrowings | 0.0 | 8.9 | 0.0 | 14.7 | 2.1 | 5.6 | 6.7 | 28.7 | 32.0 |
| Current liabilities | 39.2 | 40.5 | 30.2 | 73.7 | 71.5 | 100.6 | 144.1 | 237.3 | 273.4 |
| Non-current liabilities | 32.4 | 37.2 | 51.7 | 64.7 | 82.8 | 111.4 | 142.9 | 197.6 | 193.0 |
| Total assets | 157.6 | 158.1 | 184.0 | 228.3 | 316.7 | 439.1 | 605.9 | 1,131.0 | 1,093.9 |
| Property, plant & equipment | 11.9 | 14.7 | 16.4 | 23.6 | 37.5 | 56.0 | 75.9 | 140.4 | 140.5 |
| Capital work-in-progress | 0.5 | 3.1 | 4.2 | 4.8 | 4.9 | 5.6 | 6.5 | 1.7 | 5.3 |
| Investments | 22.5 | 7.5 | 24.2 | 4.7 | 44.1 | 54.4 | 92.3 | 263.9 | 168.5 |
| Inventories | 30.3 | 41.8 | 35.7 | 53.8 | 64.7 | 105.7 | 117.8 | 192.6 | 235.3 |
| Receivables | 32.2 | 27.8 | 32.3 | 27.2 | 28.9 | 40.5 | 58.1 | 73.5 | 84.5 |
| Cash & equivalents | 0.1 | 0.1 | 0.2 | 0.7 | 1.6 | 2.1 | 4.2 | 7.8 | 8.6 |
Cash flow
annual · ₹ crore · line = free cash flow| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 13.3 | -2.0 | -6.0 | -50.0 | -84.4 |
| Cash from investing | -26.6 | 14.7 | -12.9 | -92.2 | -313.6 |
| Cash from financing | 14.3 | -13.9 | 18.8 | 144.8 | 489.9 |
| Capex | 3.2 | 12.5 | 0.0 | 0.0 | 0.0 |
| Free cash flow | 10.1 | -14.5 | -6.0 | -50.0 | -84.4 |
| Dividends paid | 2.5 | 3.8 | 2.6 | 2.7 | 3.1 |
Where the assets sit
Sep '26 · ₹ croreFixed assets (PPE)₹140.5 cr13%
CWIP₹5.3 cr0%
Investments₹168.5 cr15%
Inventories₹235.3 cr22%
Receivables₹84.5 cr8%
Cash & equivalents₹8.6 cr1%
Other assets₹451.2 cr41%
Peer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Zota Health Care LImited | 4,264 | 1,231.10 | — | 6.82 | -18.0% |
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
1 month-8.3%
6 months-5.6%
1 year-20.9%
3Y CAGR+42.3%
5Y CAGR+27.3%
10Y CAGR—
50-day avg₹1,231.59
200-day avg₹1,250.24
RSI (14)33
FAQs
What is the share price of Zota Health Care LImited?
Zota Health Care LImited (ZOTA) closed at ₹1,231.10 on NSE on 06 Nov 2026.
What is the market cap of Zota Health Care LImited?
₹4,264 crore at the latest close.
How fast is Zota Health Care LImited growing?
Zota Health Care LImited: revenue has compounded at 56.7% a year over three years. Latest-quarter revenue is up 54.6% year on year.
How profitable is Zota Health Care LImited?
On a trailing-twelve-month basis return on equity is -18.0%, return on capital employed -15.2%, operating margin -0.0%, net margin -16.6%.
How much debt does Zota Health Care LImited have?
Zota Health Care LImited is lightly geared: debt to equity is 0.05 with borrowings of ₹32 cr against cash of ₹9 cr (balance sheet of 2026-09-30). Operating profit covers interest -4.4 times.
Financials parsed from Zota Health Care LImited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.
Zota Health Care LImited · advanced chart